Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 394260, 13 pages
http://dx.doi.org/10.1155/2015/394260
Research Article

The Construction of Common and Specific Significance Subnetworks of Alzheimer’s Disease from Multiple Brain Regions

1Information Engineering College, Shanghai Maritime University, Shanghai 201306, China
2DNJ Pharma and Rowan University, Glassboro, NJ 08028, USA
3Psychology Department, The Second People’s Hospital of Guizhou Province, Guiyang 550004, China
4Department of Computer Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China

Received 28 August 2014; Accepted 7 October 2014

Academic Editor: Tao Huang

Copyright © 2015 Wei Kong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Alzheimer’s disease (AD) is a progressively and fatally neurodegenerative disorder and leads to irreversibly cognitive and memorial damage in different brain regions. The identification and analysis of the dysregulated pathways and subnetworks among affected brain regions will provide deep insights for the pathogenetic mechanism of AD. In this paper, commonly and specifically significant subnetworks were identified from six AD brain regions. Protein-protein interaction (PPI) data were integrated to add molecular biological information to construct the functional modules of six AD brain regions by Heinz algorithm. Then, the simulated annealing algorithm based on edge weight is applied to predicting and optimizing the maximal scoring networks for common and specific genes, respectively, which can remove the weak interactions and add the prediction of strong interactions to increase the accuracy of the networks. The identified common subnetworks showed that inflammation of the brain nerves is one of the critical factors of AD and calcium imbalance may be a link among several causative factors in AD pathogenesis. In addition, the extracted specific subnetworks for each brain region revealed many biologically functional mechanisms to understand AD pathogenesis.

1. Introduction

Alzheimer’s disease (AD) is a complex progressive and irreversible neurodegenerative disease. The characteristic pathology change in AD is the deposition of beta-amyloid (Aβ) and poly-Tau protein in the cell. The pathomorphism features of AD are the senile plaques (SP) and neurofibrillary tangles (NFT), cerebrovascular amyloid, dystrophic neuritis, and loss of synaptic connections [1, 2]. AD is a complex neurodegenerative disorder with largely unknown genetic mechanisms. Lots of transcriptome studies show that AD can lead to the dysfunction of multiple brain regions and progressively destroys remembering, thinking, and reasoning skills [3]. Identifying altered gene expression and molecular mechanism in brain regions differentially affected by AD would represent a significant advance in the genetics of AD.

Most of the current genome-wide studies for AD pathogenesis focus on the hippocampus (HIP) since it is the first and most degraded region in AD brain. However, the changes of gene expression profiles, pathways, and regulatory networks are related to many brain regions which have close relationship to human learning and memory. For example, entorhinal cortex (EC) works as a hub in a widespread network for memory and navigation. The EC-hippocampus system plays an important role in declarative and spatial memories. Posterior cingulate cortex (PC) is a polymodal association area that contributes importantly to normal recognition memory and plays a critical role in visual perception. The functions of middle temporal gyrus (MTG) are associated with brain processes like recognizing familiar faces, ascertaining distance, and understanding meaning of words while reading. Superior frontal gyrus (SFG) is involved in self-awareness and in coordination with the action of the sensory system. The visual cortex (VCX) of the brain, which is responsible for processing visual information, has shown many changes in aging and AD.

In the past decades, many efforts have been made to explore the differentially expressed genes of different AD-affected brain regions. For instance, Loring et al. found that 118 significant genes were differentially expressed in the amygdala and cingulate cortex [4]. Dunckley et al. found 225 differentially expressed genes up- or downregulated in the early stages of NFT formation by comparing gene expression profiles of NFT-bearing with non-NFT-bearing entorhinal cortex neurons [5]. Liang et al. provided gene expression profiles of six brain regions from the healthy and AD-affected individuals. And then they identified differential expression changes of genes in AD pathogenesis, particularly with regard to tangle and plaque formation [6].

Recently, fast development of statistically computational tools enables large-scale discovery of coregulated gene groups and reveal of functional subnetworks for AD. Ray et al. identified 6 coexpressed gene modules, each of which represented some biological processes perturbed in the HIP of AD brain [7]. By using a weighted gene coexpression network analysis method, Miller et al. identified 12 distinct modules related to synaptic and metabolic processes and immune response in the HIP of AD patients [8]. Ray and Zhang developed a novel differential topological method to identify the coexpression network of four regions, HIP, EC, PC, and MTG from AD-affected brain, and built the topological overlap between them [9]. Liu et al. discovered the relationships among AD related pathways and dysfunctions in the six brain regions and identified the similarities and differences of these dysfunctional pathways by integrating protein-protein interaction (PPI) data [10, 11]. Liang et al. identified hub genes and the significantly perturbed subnetwork closely related to plaques and tangles from six AD-affected brain regions by using a heaviest induced subgraph algorithm with a modular scoring function [12]. Chen et al. identified gene signatures associated with six different brain regions. Functional analyses revealed that the biological processes involved with metabolism, protein ubiquitination, vasculature, and synaptic signaling pathways were dysregulated and perturbed in AD [13].

In short, the common features of the dysfunctional pathways and subnetworks extracted from various AD brain regions can provide cooperativities for potential pathogenesis. On the other hand, the distinct features and the differences among different brain regions may provide more enlightenment for finding the pathogenesis of AD. In this study, both common coexpression and specific subnetworks of six AD-affected brain regions were extracted and analyzed to find the underlying AD pathogenesis. Considering that the gene expression networks have been constructed with poor precision and accuracy due to the inherent shortcomings of small sample size and strong noise, protein-protein interaction (PPI) data was added to provide abundant translation information for extracting significant genes and functional subnetworks in this research. The heuristic algorithms and node-scoring functions were applied to integrating gene expression profiles with PPI network information to find out not only common coexpression networks, but also specific dysregulated pathways for six AD-affected brain regions, including HIP, EC, PC, MTG, SFG, and VCX. Then, simulated annealing algorithm was applied to building and optimizing the functional modules. The molecular biological analysis revealed that the inflammation reaction and calcium ions metabolism constructed by the common genes of six brain regions play important roles in AD pathogenesis. Moreover, the identified specific subnetworks for each brain region revealed many biological pathways perturbed in AD which will lead to greater insight into AD pathogenesis.

2. Methods

2.1. Score Function Principle

Score function can be used as a method for measuring the significance of genes and subnetworks. It includes edge score and node score, of which edge score represents the strength of the correlation between two node-genes and the node score represents the differential significance of each individual gene [12, 14]. The node score function can be given as follows:where represents the maximum-likelihood estimation of the shape parameter for the beta-uniform mixture (BUM) model, which indicates that the signal component is equal to the density, denotes the raw values, and represents the significance threshold, which controls the false discovery rate (FDR) for the positively scoring values and fine-tunes the discrimination of signal and noise. The raw values, which are considered as a mixture of signal and noise, can be calculated from the raw gene expression data. By this method, the noise of raw values can be easily separated since the signal component is assumed to be beta distributed, and the noise is uniform distributed [15].

The values of edge score represent the strength significance of the interaction between genes. Positive score represents activation and negative score represents inhibition. The edge significance score is given as follows:where and denote two different genes and , respectively, and denotes the Pearson correlation coefficient of the gene expression profiles of and . The differential expressions of the genes are measured as the overall expression variation ( and ). In order to avoid the influence from the number of edges, the edge score function is defined as follows:where denotes the mean of the edge score of the network and represents the standard deviation of edge scores.

2.2. The Algorithm of Identifying Differential Significance Subnetworks

The heaviest induced subgraph algorithm (Heinz) based on the node scoring was applied to our study to find out differentially significant genes and optimal subnetworks from PPI data for different brain regions. The theoretical model of Heinz algorithm belongs to a Steiner-tree problem. The main task of the model is to find an optimal network from a very complex network. In this paper, relevant subnetworks with maximal score are captured from the PPI network with negative and positive scores.

The steps of identifying a significant subnetwork by Heinz algorithm are as follows: firstly, calculate the scores of all the nodes by the score function. Next, define the edge scores based on the node scores connected to the edge. Based on these edge scores, a minimum spanning tree (MST) was calculated. Then, identify all the paths between positive nodes and at the same time the negative nodes involved in these paths were caught. Finally, calculate MST again based on the negative nodes from the obtained maximal significance subnetwork; then, the maximal subnetwork can be finally identified according to the scores of the final positive and negative nodes.

In order to increase the accuracy of the significance subnetwork, in our study, simulated annealing algorithm based on edge scores was applied to removing the weak interactions and enhancing the strong interactions of the calculated significance subnetwork. Guo et al. applied this method to analyzing human prostate cancer and yeast cell cycle. Their results demonstrated that the edge-based method was able to efficiently capture relevant protein interaction behaviors under the investigated conditions [14]. Simulated annealing algorithm is a widely used intelligent optimization algorithm in a number of fields [16]. The modular analysis of biological networks in the bioinformatics research can be considered as a large-scale combinatorial optimization problem essentially. Meanwhile the simulated annealing algorithm is an effective approximation algorithm for solving these kinds of large-scale combinatorial optimization problems with the advantage of avoiding falling into the local optimization.

3. Results and Discussion

3.1. Data and Preprocessing

The gene expression datasets of healthy elders and AD patients we used in this study were downloaded from NCBI GEO Datasets-record of GSE5281. The neurons were collected by laser-capture microdissection from six different brain regions, including HIP, EC, MTG, PC, SFG, and primary visual cortex (VCX). The human GeneChips Affymetrix U133 Plus 2.0 array was used to provide the gene expression data. Each gene chip involved 54675 genes probes for each sample. The datasets consisted of 13 control (normal aging) and 10 AD-affected samples for HIP, the same sample number for EC, 12 control and 16 AD-affected samples for MTG, 13 control and 9 AD-affected samples for PC, 11 control and 23 AD-affected samples for SFG, and 12 control and 19 AD-affected samples for VCX. Moreover, the PPI datasets we utilized in this research are obtained from the Human Protein Reference Database (HPRD) [17], which consisted of 36504 interactions among 9386 genes.

Before searching for differential significance subnetworks with maximal scores, we matched the preprocessed gene expression data with PPI dataset to get the raw interactions of genes (nodes) with the related edges, and the raw values of all the nodes were calculated as well. Secondly, we processed the gene expression data by gene annotation and variance analysis. For PPI dataset, self-loops and proteins without expression values were removed for simplifying the raw protein interaction networks. Next, the Affymetrix probe set IDs and HPRD gene symbols were mapped to Entrez Gene IDs to extract maximal network. After the preprocessing, there are around 6100–6400 genes left for each brain region.

3.2. Results and Discussion

According to our experiments, adjusting the FDR into different values will obtain different number of genes with positive scores; in order to insure plenty of gene nodes with positive scores, for each brain region, we selected different suitable FDR for the PPI network by which each raw network can contain about 15% positive score nodes. The FDR for HIP, EC, MTG, PC, SFG, and VCX region were set to be 0.008, 0.004, 0.0007, 0.01, 0.06, and 0.09, respectively. The node scores and edge scores for each brain region dataset were calculated. Starting from the positive score nodes, Heinz algorithm was applied to searching for the maximal scoring subnetworks in each brain region. After that the simulated annealing algorithm was applied to optimizing the networks with the threshold value of 0.8. By using the simulated annealing algorithm, the interactions with the edge strength exceeding the threshold were added to the extracted subnetworks, while the weak strengths whose value was less than the threshold were removed from the subnetworks. Six differential significance subnetworks were finally identified for the six brain regions, respectively. Based on that, we carried out the functional enrichment analysis for the identified subnetworks by Gene Ontology (GO) and DAVID [18]. Many known risk genes and pathways were extracted in our results such as APP and GAPDH. Additionally, NF-κB signaling pathway, pathways associated with mitochondria, nerve tissue, calcium ion metabolism, and process of acetylation were also identified and shown to be closely associated with the pathogenetic mechanism of AD.

By observing the genes and interactions of these six identified significance subnetworks, it was found that they were overlapped with each other. The overlapped genes and interactions may suggest that the similarities may play important roles in the dysregulated networks in AD. Figure 1 provided the Venn diagram of the overlap of the significance subnetworks among five brain regions.

Figure 1: The Venn diagram of five brain regions with significant genes.

From Figure 1 we can see that many significantly expressed genes overlapped between different brain regions. Additionally, many other genes were specifically differentially expressed in each brain region as well. Therefore, the consideration for both common and specific genes and subnetworks were necessary to discover the pathogenetic mechanism of AD.

3.2.1. Molecular Biological Analysis of Common Functional Subnetworks

For the genes overlapped in overall the six brain regions, we selected a gene as a common gene when the number of interactions with other genes exceeds 90% quantile in different subnetworks. With this criterion, 206 common genes were extracted. It showed that most of the common genes play important roles in different brain regions. The molecular biological analysis revealed that many common genes were functionally related to metabolism, synaptic vesicle-mediated transport, transcriptional regulation, protein kinase phosphorylation, apoptosis, intracellular signaling, and cell cycle. Particularly, two functional subnetworks consisted of the common genes, which closely related to inflammation and calcium imbalance, were found distinctly dysregulated in all of the AD-affected brain regions. Figure 2 showed the inflammatory response subnetwork constructed by the related common genes. Diamonds in Figure 2 denoted the known risk genes of AD, circles presented our extracted common genes related to inflammation, and their different colors indicated different numbers of brain regions in which the gene was upregulated or downregulated. Table 1 provided the KEGG pathway analysis of genes in Figure 2.

Table 1: KEGG pathway analysis results.
Figure 2: Functional subnetwork of the inflammatory response constructed by common genes.

From Figure 2 and Table 1 we can see that many regions of the AD brain suffered from inflammation. The degeneration of tissue and the deposition of beta-amyloid (Aβ) and poly-Tau protein are known as the classical stimulants of inflammation [19]. Mitogen-activated protein kinases (MAPKs) are serine-threonine kinases that mediate various types of cellular activities including cell proliferation, differentiation, survival, death, and transformation [20, 21]. The dysregulation of MAPK signaling pathways was found to have involved in many human diseases including AD, Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and many kinds of cancers [22]. The activation of ERK, JNK, and p38 signaling pathways may lead to neuronal apoptosis in AD [23]. In Figure 2, our results indicated that the crowd MAPK1 and MAKP3 expressions were lower than the normal samples obviously in most of the six AD brain regions.

Our results in Figure 2 also showed that caspase-3, Bcl2, caspase-6, and caspase-8 were overexpressed in most of the six AD brain regions. Caspases are a family of cysteine proteases that plays an important role in apoptosis (programmed cell death), necrosis, and inflammation [24, 25]. The predominant caspase involved in the cleavage of amyloid-beta precursor protein (APP) is suggested to be associated with neuronal death in AD [26]. The Bax gene was the first identified proapoptotic member of the Bcl2 protein family; Bax and caspase-3 are both death effectors in neurodegenerative pathways [27]. It implicates that nervous cells apoptosis will occur. The extracted common genes in our results are in keeping with recently pathological analysis. Furthermore, our results also showed that APP was overexpressed in AD samples in all of the six brain regions. The overexpression of APP would activate caspase-3 in human postmitotic neurons and cause the degeneration of postmitotic neurons in AD [28].

The SOCS (suppressors of cytokine signaling) family of proteins has a dual identity; they are the inhibitors of JAK (Janus kinase) signal transducer and the activator of the STAT signaling pathways as well [29]. The subtype SOCS3 has an important function in inhibiting some inflammatory genes, cytokine signaling, and STAT3 activation. The STAT3 has dual function in different types of cells; on the one hand, it promotes proliferation and prevents apoptosis; on the other hand, it can induce growth arrest and apoptosis [30, 31]. Our data exhibited that SOCS3 and STAT3 were both overexpressed in six AD brain regions.

Furthermore, TNFRSF1A protein works as a regulator of inflammation, and as a receptor of TNF-α (tumor necrosis factor-alpha) it can activate NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) and mediate apoptosis [32]. Our data show that TNFRSF1A and TNF-α were both overexpressed. The results confirmed that the six AD brain regions closely associated with inflammation and apoptosis.

In addition to inflammatory response, another important subnetwork we found from the common genes was calcium ion metabolism subnetwork. Figure 3 showed the subnetwork of the calcium ion mechanism with the extracted common genes, and the KEGG pathway analysis of this subnetwork was provided in Table 2.

Table 2: KEGG pathway analysis results.
Figure 3: Functional subnetwork of the calcium ion mechanism constructed by common genes.

In AD-affected brain regions, the calcium ion metabolism related signaling were found dysregulated. It was reported that calcium can modulate many neural processes, including synaptic plasticity and apoptosis. With the increase of the intracellular calcium, the accumulation of amyloid-β, the hyperphosphorylation of Tau, and neuronal death will occur in the affected brain regions [33]. Particularly, in this subnetwork, our results showed that APP was greatly upregulated in HIP, PC, MTG, and VCX. In addition, Annexin is a Ca (2+)-effector protein which plays an important role in the metabolism of intracellular Ca (2+) [34]. Annexin A2 is a calcium-dependent phospholipid-binding protein whose function is to help organize exocytosis of intracellular proteins to the extracellular domain. Figure 3 showed that ATP2A2 and ATP2B2 were lower expressed than normal samples in overall the six AD brain regions. ATP2A2 and ATP2B2 are enzymes that can remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis [35, 36].

3.2.2. Specific Subnetworks in Each Brain Region

Figure 1 revealed that many significant genes were specially expressed in different brain regions. It suggested that some specific dysregulated pathways and subnetworks among them will provide deep insights into the pathogenetic mechanism of AD. By getting rid of the common genes overlapped in different brain regions, the maximal scoring function and the simulated annealing method were used again to construct the specific functional subnetwork by the specifically differential significant genes for each brain region including HIP, EC, PC, MTG, and SFG. Therefore, the sizes of the constructed specific subnetworks are much smaller. Since there were not enough significant genes that can be discovered to construct any functional subnetwork, the result of primary visual cortex (VCX) was absence. Figures 48 showed the specific functional subnetworks in HIP, EC, PC, MTG, and SFG, respectively. In Figures 48, red circles represented the genes upregulated in this brain region for AD samples, blue circles denoted the genes downregulated, and grey ones denoted that this gene had no great changes compared with normal samples in this brain area.

Figure 4: Specific subnetwork of HIP.
Figure 5: Specific subnetwork of EC.
Figure 6: Specific subnetwork of PC.
Figure 7: Specific subnetwork of MTG.
Figure 8: Specific subnetwork of SFG.

For HIP, among the specific significant genes, 33 genes can be constructed to the maximal scoring subnetwork (Figure 4). It is known that for AD patients the hippocampus is one of the first regions of the brain to suffer damage including memory loss and disorientation. In this region, some genes were specially differentially overexpressed, such as CAPN1, FXR1, GRIN2B, ITPR1, KDR, KIAA1377, NBN, PRKG1, RUNX1T1, SGSM2, SREBF2, TAF15, and U2AF2. CAPN1 (calcium-activated neutral protease) is a kind of nonlysosomal intracellular cysteine protease. The overexpression of CAPN1 has a relationship with intractable epilepsy as well as the clinicopathological characteristics in AD patients [37]. It was interesting to note that kinase 1 was low expressed in AD, but it was known to be high expressed in cancer.

In EC area, 40 specially expressed genes were constructed to the maximal scoring subnetwork (Figure 5). The changes in the Tau protein and the cleaved fragments of APP have been found in EC region in the early stages of AD [38]. In this brain area, our data showed that BRAF, C21orf91, CBL, CSF2RB, LYN, MDM2, SLA, and KANK1 were all overexpressed. BRAF, as a member of the RAF kinase family of growth signal transduction protein kinases, can affect cell division, differentiation, and secretion by regulating the MAP kinase/ERKs signaling pathway [39]. Members of the Casitas B-lineage lymphoma (Cbl) protein family are evolutionarily conserved multidomain regulators of signal transduction. Colony stimulating factor 2 receptor β (CSF2RB) is a risk factor in both schizophrenia and major depression since the overexpression of it has relationship with the disturbance of nerve signal conduction [40]. AKT1 is a survival factor and the activated AKT1 plays important roles in inhibiting apoptosis and promoting cell survival [41, 42]. Our results showed that AKT1 was low expressed in EC of AD patients which indicated that apoptosis was happening.

Figure 6 shows the maximal scoring subnetwork of PC area constructed by 16 specifically significant genes. PC is a polymodal association area that contributes importantly to normal recognition memory and plays a critical role in visual perception [43, 44]. From Figure 6 we can see that genes CASP3, CASP6, CDKN1A, FLNA, ITGB1, MAPT, PCBP2, PRKACA, and SET were overexpressed in PC area of AD brain. The genes CASP3 and CASP6 are related to apoptosis. CDKN1A (p21) has a function of regulating cell cycle by inhibiting the activity of cyclin-CDK2, cyclin-CDK1, and cyclin-CDK4/6 complexes and it activates CDK2; thus, it leads to apoptosis [45, 46]. The Tau proteins are the product of alternative splicing from a single gene that is designated MAPT (microtubule-associated protein tau) in humans, and the overexpression of Tau will impact a neuroinflammation gene expression network perturbed in AD [2, 47, 48]. The major human AP endonuclease APE1 are reported to play an important role in the base excision repair (BER) pathway [49]; however, they were found to be low expressed in PC area of AD brains.

In MTG area, 24 specifically significant genes were extracted to achieve a maximal scoring subnetwork (Figure 7). The functions of MTG are associated with brain processes like recognizing familiar faces, ascertaining distance, and understanding meaning of words while reading. Our data exhibited that ANTXR1, BRCA1, CCND1, GATA2, KMT2D, NEDD9, PITPNM3, PLCG2, PRTFDC1, RB1CC1, SMAD1, and STAT5A were overexpressed. The ANTXR1 is a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. Aldose reductase contributes to diabetes-mediated mitochondrial dysfunction and damage through the activation of p53. The degree of mitochondrial dysfunction and damage determines whether hyperactivity (mild damage) or apoptosis (severe damage) will ensue [50]. BRCA1 is part of a complex that repairs double-strand breaks in DNA [51]; the overexpression of BRCA1 may suggest that DNA damage is serious; but BRCA1 mutation carriers are at an increased risk of prostate and breast cancer [52]. CCNDBP1 belongs to cyclin D family. The expression of cyclin D suggests that act to link growth factor signals with cell cycle transitions during G1 [53].

For the SFG area, there were 15 specifically significant genes that can be used to construct a maximal scoring subnetwork (Figure 8). SFG is involved in self-awareness and in coordination with the action of the sensory system [54]. In this region, genes CAV1, CDH5, EDNRB, GJB2, JUP, GJB6, and PPAP2B were found overexpressed in AD brains. The CDH5 gene is a classical cadherin from the cadherin superfamily, which provides a molecular system reflecting both early embryonic and mature nervous system architecture. In AD crowd, overexpression of cadherins may be related to restoration of neural epithelium [55, 56]. The PTPN6, which is a member of the PTP (protein tyrosine phosphatase) family, was downregulated in SFG area of AD brain. PTP family is reported to have the ability to regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation [57, 58].

4. Conclusions

AD progression is known to occur in many brain regions which have close relationship of human learning and memory with particular features. Discovering the common and specific changes and dysregulated pathways of different brain regions will provide deep insights for finding of the pathogenesis of AD. In this study, we applied a method of scoring function and simulated annealing algorithm to constructing and optimizing the differential significance subnetworks for six brain regions including hippocampus (HIP), entorhinal cortex (EC), middle temporal gyrus (MTG), posterior cingulate cortex (PC), superior frontal gyrus (SFG), and primary visual cortex (VCX). The common genes we identified from overall the six brain regions revealed two significant functional subnetworks which showed that the dysregulation of inflammation and calcium metabolism play important roles in the onset and deterioration of AD. For example, the dysregulated MAPK signaling pathways and JNK or p38 signaling pathways, as parts of inflammation subnetwork, were demonstrated to be associated with many cellular activities and neuronal apoptosis in AD. Many common genes such as caspases, SOCS3, STAT3, TNFRSF1A, and TNF-α were confirmed to have close association with inflammation and apoptosis in all the six AD brain regions. In calcium ion mechanism subnetwork, many genes such as ATP2A2 and ATP2B2 played a critical role in intracellular calcium homeostasis. The dysregulation of intracellular calcium would lead to the accumulation of amyloid-β, hyperphosphorylation of Tau, and neuronal death which are parts of the known pathogenesis of AD.

Although we highlighted the contributions of the inflammation and calcium imbalance subnetworks as common features for six brain regions, this paper illustrated the specific dysregulated subnetworks in each AD-affected brain region for HIP, EC, PC, MTG, and SFG. In the subnetwork of HIP, many differentially expressed genes were identified as the clinicopathological characteristics of AD. EC, as another area early affected by AD, was characterized by changes in the Tau protein and APP. Many significant genes in EC played central roles in regulating the MAP kinase/ERKs signaling pathway and affected cell division, differentiation, and secretion. The specific expressed genes in PC area showed close relationship of apoptosis and cell cycle progression. Particularly, the overexpression of Tau will impact a neuroinflammation gene expression network perturbed in AD. The specifically expressed genes in the subnetwork in MTG area of AD showed that they effected the mitochondrial dysfunction and DNA damage. The significant genes related to cadherins in SFG area suggested that this area may contribute to the formation and maintenance of segmental and functional nervous system structures.

In summary, our molecular biological analysis demonstrated that the identified common and specific maximal scoring subnetworks help in comparing biological phenomena across AD-affected brain regions and obtaining a global overview of the disease, which can enable us to further understand the pathogenetic mechanism of AD.

Conflict of Interests

The authors declare no conflict of interests.

Acknowledgment

This work was supported by the National Natural Science Foundations of China (no. 61271446, 31170952, and 61003093).

References

  1. M. Meyer-Luehmann, T. L. Spires-Jones, C. Prada et al., “Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease,” Nature, vol. 451, no. 7179, pp. 720–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. D. Wes, A. Easton, J. Corradi et al., “Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease,” PLoS ONE, vol. 9, no. 8, Article ID e106050, 2014. View at Publisher · View at Google Scholar
  3. C. Hock, K. Heese, C. Hulette, C. Rosenberg, and U. Otten, “Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas,” Archives of Neurology, vol. 57, no. 6, pp. 846–851, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. J. F. Loring, X. Wen, J. M. Lee, J. Seilhamer, and R. Somogyi, “A gene expression profile of Alzheimer's disease,” DNA and Cell Biology, vol. 20, no. 11, pp. 683–695, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Dunckley, T. G. Beach, K. E. Ramsey et al., “Gene expression correlates of neurofibrillary tangles in Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 10, pp. 1359–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. W. S. Liang, T. Dunckley, T. G. Beach et al., “Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set,” Physiological Genomics, vol. 33, no. 2, pp. 240–256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Ray, J. Ruan, and W. Zhang, “Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases,” Genome Biology, vol. 9, no. 10, article R148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Miller, M. C. Oldham, and D. H. Geschwind, “A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging,” The Journal of Neuroscience, vol. 28, no. 6, pp. 1410–1420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Ray and W. Zhang, “Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks,” BMC Systems Biology, vol. 4, article 136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Z.-P. Liu, Y. Wang, X.-S. Zhang, and L. Chen, “Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains,” BMC Systems Biology, vol. 4, no. 2, article 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Z.-P. Liu, Y. Wang, X.-S. Zhang, W. Xia, and L. Chen, “Detecting and analyzing differentially activated pathways in brain regions of Alzheimer's disease patients,” Molecular BioSystems, vol. 7, no. 5, pp. 1441–1452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Liang, G. Han, X. Feng, J. Sun, Y. Duan, and H. Lei, “Concerted perturbation observed in a hub network in Alzheimer's disease,” PLoS ONE, vol. 7, no. 7, Article ID e40498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Chen, Q. Guan, Z.-Y. Nie, and L.-J. Jin, “Gene expression profile and functional analysis of Alzheimer's disease,” American Journal of Alzheimer's Disease and other Dementias, vol. 28, no. 7, pp. 693–701, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Guo, L. Wang, Y. Li et al., “Edge-based scoring and searching method for identifying condition-responsive protein-protein interaction sub-network,” Bioinformatics, vol. 23, no. 16, pp. 2121–2128, 2007. View at Google Scholar
  15. M. T. Dittrich, G. W. Klau, A. Rosenwald, T. Dandekar, and T. Müller, “Identifying functional modules in protein-protein interaction networks: an integrated exact approach,” Bioinformatics, vol. 24, no. 13, pp. i223–i231, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Ding, P. Yang, and X. H. Wu, “Application of simulated annealing algorithm to biological network research,” Computers and Applied Chemistry, vol. 28, no. 10, pp. W1302–W1304, 2011. View at Google Scholar
  17. W. E. Müller, A. Eckert, C. Kurz, G. P. Eckert, and K. Leuner, “Mitochondrial dysfunction: common final pathway in brain aging and alzheimer's disease-therapeutic aspects,” Molecular Neurobiology, vol. 41, no. 2-3, pp. 159–171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Akiyama, S. Barger, S. Barnum et al., “Inflammation and Alzheimer's disease,” Neurobiology of Aging, vol. 21, no. 3, pp. 383–421, 2000. View at Google Scholar
  20. J. A. McCubrey, M. M. Lahair, and R. A. Franklin, “Reactive oxygen species-induced activation of the MAP kinase signaling pathways,” Antioxidants & Redox Signaling, vol. 8, no. 9-10, pp. 1775–1789, 2006. View at Google Scholar
  21. S. Torii, T. Yamamoto, Y. Tsuchiya, and E. Nishida, “ERK MAP kinase in G1 cell cycle progression and cancer,” Cancer Science, vol. 97, no. 8, pp. 697–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. S. Dhillon, S. Hagan, O. Rath, and W. Kolch, “MAP kinase signalling pathways in cancer,” Oncogene, vol. 26, no. 22, pp. 3279–3290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. E. K. Kim and E.-J. Choi, “Pathological roles of MAPK signaling pathways in human diseases,” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1802, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. E. S. Alnemri, D. J. Livingston, D. W. Nicholson et al., “Human ICE/CED-3 protease nomenclature,” Cell, vol. 87, no. 2, p. 171, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. D. R. McIlwain, T. Berger, and T. W. Mak, “Caspase functions in cell death and disease,” Cold Spring Harbor Perspectives in Biology, vol. 5, no. 4, Article ID a008656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Bulat and C. Widmann, “Caspase substrates and neurodegenerative diseases,” Brain Research Bulletin, vol. 80, no. 4-5, pp. 251–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. Chong, M. R. Murray, E. C. Gosink et al., “Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 2, pp. 889–894, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Uetsuki, K. Takemoto, I. Nishimura et al., “Activation of neuronal caspase-3 by intracellular accumulation of wild- type Alzheimer amyloid precursor protein,” Journal of Neuroscience, vol. 19, no. 16, pp. 6955–6964, 1999. View at Google Scholar · View at Scopus
  29. D. L. Krebs and D. J. Hilton, “SOCS: physiological suppressors of cytokine signaling,” Journal of Cell Science, vol. 113, part 16, pp. 2813–2819, 2000. View at Google Scholar · View at Scopus
  30. Y. Lu, S. Fukuyama, R. Yoshida et al., “Loss of SOCS3 gene expression converts STAT3 function from anti-apoptotic to pro-apoptotic,” The Journal of Biological Chemistry, vol. 281, no. 48, pp. 36683–36690, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Qin, W.-I. Yeh, P. de Sarno et al., “Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 13, pp. 5004–5009, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Li and X. Lin, “Positive and negative signaling components involved in TNFα-induced NF-κB activation,” Cytokine, vol. 41, no. 1, pp. 1–8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. F. M. LaFerla, “Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 3, no. 11, pp. 862–872, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Gerke, C. E. Creutz, and S. E. Moss, “Annexins: linking Ca2+ signalling to membrane dynamics,” Nature Reviews Molecular Cell Biology, vol. 6, no. 6, pp. 449–461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Hadri, R. G. Kratlian, L. Benard et al., “Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension,” Circulation, vol. 128, no. 5, pp. 512–523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. E. M. Lynes, A. Raturi, M. Shenkman et al., “Palmitoylation is the switch that assigns calnexin to quality control or ER Ca2+ signaling,” Journal of Cell Science, vol. 126, no. 17, pp. 3893–3903, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Z.-H. Feng, J. Hao, L. Ye et al., “Overexpression of μ-calpain in the anterior temporal neocortex of patients with intractable epilepsy correlates with clinicopathological characteristics,” Seizure, vol. 20, no. 5, pp. 395–401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. U. A. Khan, L. Liu, F. A. Provenzano et al., “Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease,” Nature Neuroscience, vol. 17, no. 2, pp. 304–311, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. G. Daum, I. Eisenmann-Tappe, H. W. Fries, J. Troppmair, and U. R. Rapp, “The ins and outs of Raf kinases,” Trends in Biochemical Sciences, vol. 19, no. 11, pp. 474–480, 1994. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Chen, K. Huang, G. Zhou et al., “Common SNPs in CSF2RB are associated with major depression and schizophrenia in the Chinese Han population,” World Journal of Biological Psychiatry, vol. 12, no. 3, pp. 233–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. T. F. Franke, S.-I. Yang, T. O. Chan et al., “The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase,” Cell, vol. 81, no. 5, pp. 727–736, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Dudek, S. R. Datta, T. F. Franke et al., “Regulation of neuronal survival by the serine-threonine protein kinase Akt,” Science, vol. 275, no. 5300, pp. 661–665, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. W. A. Suzuki, “The anatomy, physiology and functions of the perirhinal cortex,” Current Opinion in Neurobiology, vol. 6, no. 2, pp. 179–186, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. R. R. Hampton, “Monkey perirhinal cortex is critical for visual memory, but not for visual perception: reexamination of the behavioural evidence from monkeys,” Quarterly Journal of Experimental Psychology Section B: Comparative and Physiological Psychology, vol. 58, no. 3-4, pp. 283–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. L. Gartel and S. K. Radhakrishnan, “Lost in transcription: p21 repression, mechanisms, and consequences,” Cancer Research, vol. 65, no. 10, pp. 3980–3985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. H. Jin, K. J. Yoo, Y. H. Lee, and S. K. Lee, “Caspase 3-mediated cleavage of p21(WAF1/CIP1) associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells,” The Journal of Biological Chemistry, vol. 275, no. 39, pp. 30256–30263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Goedert, C. M. Wischik, R. A. Crowther, J. E. Walker, and A. Klug, “Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 11, pp. 4051–4055, 1988. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Goedert, M. G. Spillantini, R. Jakes, D. Rutherford, and R. A. Crowther, “Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease,” Neuron, vol. 3, no. 4, pp. 519–526, 1989. View at Publisher · View at Google Scholar · View at Scopus
  49. A. E. Vidal, S. Boiteux, I. D. Hickson, and J. P. Radicella, “XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions,” The EMBO Journal, vol. 20, no. 22, pp. 6530–6539, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. W. H. Tang, J. Stitham, Y. Jin et al., “Aldose reductase-mediated phosphorylation of p53 leads to mitochondrial dysfunction and damage in diabetic platelets,” Circulation, vol. 129, no. 15, pp. 1598–1609, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. I. H. Ismail, R. Davidson, J. P. Gagné et al., “Germline mutations in BAP1 impair its function in DNA double-strand break repair,” Cancer Research, vol. 74, no. 16, pp. 4282–4294, 2014. View at Google Scholar
  52. A. Liede, B. Y. Karlan, and S. A. Narod, “Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature,” Journal of Clinical Oncology, vol. 22, no. 4, pp. 735–742, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. C. J. Sherr, H. Matsushime, and M. F. Roussel, “Regulation of CYL/cyclin D genes by colony-stimulating factor 1,” Ciba Foundation Symposium, vol. 170, pp. 209–219, 1992. View at Google Scholar · View at Scopus
  54. I. I. Goldberg, M. Harel, and R. Malach, “When the brain loses its self: prefrontal inactivation during sensorimotor processing,” Neuron, vol. 50, no. 2, pp. 329–339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Graziani, M. Poteser, W.-M. Heupel et al., “Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-β-catenin interaction,” The Journal of Biological Chemistry, vol. 285, no. 6, pp. 4213–4223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Redies and M. Takeichi, “Cadherins in the developing central nervous system: an adhesive code for segmental and functional subdivisions,” Developmental Biology, vol. 180, no. 2, pp. 413–423, 1996. View at Publisher · View at Google Scholar · View at Scopus
  57. R. Cao, Q. Ding, P. Li et al., “SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer,” Radiation Oncology, vol. 8, no. 1, article 178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. L. Sooman, S. Ekman, G. Tsakonas et al., “PTPN6 expression is epigenetically regulated and influences survival and response to chemotherapy in high-grade gliomas,” Tumor Biology, vol. 35, no. 5, pp. 4479–4488, 2014. View at Publisher · View at Google Scholar · View at Scopus